logo
16:01 May 29

Colinz Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
53.47
+2.54 (+4.99%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Colinz Laboratories Ltd. Financials

Colinz Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
53.47
+2.54 (+4.99%)
16:01 May 29
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

48/100
Mid Valuation

Technical

59/100
Technically Neutral

Strength

9

Weakness

3

Opportunity

0

Threats

0

5.12 %

ROE %

4.02 %

ROA %

0.00

EPS

39.87

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
6.97 7.15 7.03 6.53 6.14
Operating Expenses +
6.38 6.55 6.48 6.04 5.72
Raw Material
1.97 2.33 2.23 2.01 1.69
Increase Decrease in Cost
0.33 -0.03 0.08 0.08 0.02
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2.9 3.03 2.95 2.84 2.7
Miscellaneous Expenses
3.92 4.64 4.66 4.01 3.55
Operating Profit
0.59 0.6 0.55 0.49 0.42
Other Income
0.17 0.17 0.28 0.3 0.48
Depreciation
0.2 0.13 0.13 0.13 0.16
Interest
0.08 0.05 0.04 0.04 0.05
Profit before tax and exceptio..
0.48 0.6 0.65 0.62 0.69
Exceptional Items
0 0 0 0 0
PBT
0.48 0.6 0.65 0.62 0.69
Provision for Taxation
0.14 0.14 0.16 0.12 0.17
Net Profit
0.34 0.46 0.49 0.5 0.51
NET Profit after MI
0 0 0 0 0
EPS
0.74 1.82 1.93 1.97 2.04
Operating Profit Margin (%)
8.46 8.39 7.82 7.5 6.84
Net Profit Margin (%)
4.88 6.43 6.97 7.66 8.31

Colinz Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 66.00 66.00 66.00 66.00 66.00 66.00
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 34.00 34.00 34.00 34.00 34.00 34.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: